Contact
University Hospital Zurich
Department of Cardiology
Education
Rämistrasse 100
CH-8091 Zurich
19.09.2024 | 13.30 - 19.00 | Thursday |
---|---|---|
20.09.2024 | 8.30 a.m. - 7 p.m. | Friday |
1:30 pm | Welcome speech Firat Duru (Zurich) and Corinna Brunckhorst (Zurich) |
---|---|
1:40 pm | Opening remarks Monika Jänicke (Zurich) |
1:45 pm | Introduction: Rationale for a new international expert consensus document on arrhythmogenic cardiomyopathy Hugh Calkins (Baltimore) and Firat Duru (Zurich) |
General sessions (I) (Each presentation is followed by 10 minutes of discussion) Chairs: William McKenna (London) and Gaetano Thiene (Padua) |
|
2:00 pm | Pathology of arrhythmogenic cardiomyopathy Cristina Basso (Padua) and Jeffrey Saffitz (Boston) |
2:25 pm | Pathophysiology and mechanisms of disease Mario Delmar (London) and Chantal van Opbergen (Amsterdam) |
3:00 p.m. | Genetic basis of disease Peter van Tintelen (Amsterdam) and Cynthia James (Baltimore) |
3:30 p.m. | Coffee break |
General sessions (II) (Each presentation is followed by 10 minutes of discussion) Chairs: Richard Hauer (Utrecht) and Wojciech Zareba (Rochester) General approach to diagnostic testing |
|
4:00 pm | Electrocardiography Pyotr Platonov (Lund) |
4:20 pm | Echocardiography Kristina Haugaa (Oslo) |
4:40 pm | Magnetic resonance imaging Stefan Zimmerman (Baltimore) |
5:00 pm | Risk stratification in arrhythmogenic cardiomyopathy Julia Cadrin-Tourigny (Montreal) |
5:30 p.m. | Effects of physical activity Ardan Saguner (Zurich)ICD and catheter ablation: Hari Tandri (Nashville) Gene-based therapies: TBD |
6:00 pm | Arrhythmogenic cardiomyopathy at a young age: special considerations for the pediatric population Dominic Abrams (Boston) and Juan Pablo Kaski (London) |
6:30 pm | Concluding remarks Frank Ruschitzka (Zurich) |
6:35 pm | Cocktail |
7:00 pm | Faculty Dinner |
8:30 a.m. | Opening remarks Corinna Brunckhorst (Zurich) |
---|---|
Genotype sessions (I) (Each presentation is followed by 10 minutes of discussion) Chairs: Firat Duru (Zurich) and Hugh Calkins (Baltimore) |
|
8:35 a.m. | Plakophilin-2 (PKP2) cardiomyopathy Cynthia James (Baltimore) and Anneline te Riele (Utrecht) |
9:20 a.m. | Desmoglein-2 (DSG2) / Desmocollin-2 (DSC2) Cardiomyopathy Julia Cadrin-Tourigny (Montreal) and Daniel Judge (Charleston) |
10:00 a.m. | Desmoplakin (DSP) cardiomyopathy Adam Helms (Ann Arbor) and Kalliopi Pilichou (Padova) |
10:40 a.m. | Coffee break |
11:20 a.m. | Phospholamban (PLN) cardiomyopathy Moniek Cox (Utrecht) and Peter van Tintelen (Amsterdam) |
12:20 pm | Transmembrane protein 43 (TMEM43) cardiomyopathy Kathy Hodgkinson (St. John’s) and Sean Connors (St. John’s) |
1:00 pm | Lunch Break |
Genotype sessions (II) (Each presentation is followed by 10 minutes of discussion) Chairs: Corinna Brunckhorst (Zurich) and Hugh Calkins (Baltimore) |
|
2:00 pm | Plakoglobin (JUP) cardiomyopathy Alexandros Protonotarios (London) and Adalena Tsatsopoulou (Athens) |
2:35 pm | Desmin (DES) cardiomyopathy Juan Jimenez Jaimez (Granada) and Andreas Barth (Baltimore) |
3:10 pm | Filamin-C (FLNC) cardiomyopathy Luisa Mestroni (Denver) and Job Verdonschot (Maastricht) |
3:40 pm | Cadherin-2 (CDH2) cardiomyopathy Lia Crotti (Milan) and Paolo Cerea (Milan) |
4:10 pm | Coffee break |
Genotype sessions (III) Treatment of arrhythmogenic cardiomyopathy
(Each lecture will be followed by 10 minutes of discussion) |
|
4:40 pm | Antiarrhythmic therapy Wojciech Zareba (Rochester) |
5:00 pm | ACE inhibitors, ARBs and aldosterone inhibitors Larissa Fabritz (Hamburg) |
5:20 pm | Implantable Cardioverter Defibrillator Andrew Krahn (Vancouver) |
5:40 pm | Catheter ablation Harikrishna Tandri (Nashville) |
6:00 pm | Summary of Day 2 and closing remarks Hugh Calkins (Baltimore) and Firat Duru (Zurich) |
7:00 pm | Gala Dinner |
University Hospital Zurich
Department of Cardiology
Education
Rämistrasse 100
CH-8091 Zurich
The 6th Zurich International Symposium on Arrhythmogenic Cardiomyopathies is mainly sponsored by the “Georg and Bertha Schwyzer-Winiker Foundation”, as well as partners from the pharmaceutical / medtech industry.